摘要
医药研发领域的迅速发展带来了职业健康管理的新挑战,主要包括研发过程的高度不确定性、各类新型危害以及新业态合规管理的挑战,而传统管理模式在应对职业健康风险方面具有局限性。本文基于敏捷治理视角,提出动态响应、弹性适配以及多元协同的优化路径,并从理念更新、机制创新与工具赋能三方面提出对策建议,旨在为医药研发行业创新发展中职业健康风险的有效管控提供参考。
The rapid development of the pharmaceutical research and development(R&D)has brought new challenges to occupational health management,including the high uncertainty in the R&D process,emerging hazards,and compliance complexities associated with novel business models.Traditional management approaches exhibit limitations in effectively addressing the oc-cupational health risks associated with these challenges.Based on the perspective of agile gover-nance,this paper proposed an optimized pathway characterized by dynamic response,adaptive flexibility,and multi-stakeholder collaboration.It further offered countermeasures and recom-mendations from three aspects:concept renewal,mechanism innovation,and tool empower-ment,aiming to provide reference for the effective management and control of occupational health risks in the innovation and development of the pharmaceutical R&D industry.
作者
张霞
唐颖
于曼
陈健
朱素蓉
ZHANG Xia;TANG Ying;YU Man;CHEN Jian;ZHU Surong(Shanghai Municipal Center for Disease Control and Prevention,Shanghai 201107,China;Shanghai Municipal Health Commission,Shanghai 200125,China)
出处
《环境与职业医学》
北大核心
2025年第10期1247-1251,共5页
Journal of Environmental and Occupational Medicine
基金
上海市卫生健康委员会标准预研制项目(2022WB12,2023WB18)。
关键词
医药
研发
新业态
职业健康管理
敏捷治理
pharmaceutical
research and development
new business model
occupational health management
agile governance
